MoneyWorks4Me

Medicamen Biotech - Quaterly Results

08 Aug 2023 Evaluate
The Revenue for the quarter ended  June 2023 of Rs. 405.03 millions grew by 22.41 % from Rs. 330.88 millions.A humble growth in net profit of 23.20% reported in the quarter ended June 2023 to Rs. 44.18  millions from Rs. 35.86 millions.Operating profit surged to 77.90 millions from the corresponding previous quarter of 66.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 405.03 330.88 22.41 405.03 330.88 22.41 1378.84 1154.45 19.44
Other Income 3.79 9.62 -60.60 3.79 9.62 -60.60 24.62 17.20 43.14
PBIDT 77.90 66.19 17.69 77.90 66.19 17.69 266.09 252.74 5.28
Interest 9.56 7.67 24.64 9.56 7.67 24.64 29.23 14.01 108.64
PBDT 68.34 58.52 16.78 68.34 58.52 16.78 236.86 238.73 -0.78
Depreciation 16.80 15.27 10.02 16.80 15.27 10.02 63.54 57.71 10.10
PBT 51.54 43.25 19.17 51.54 43.25 19.17 173.32 181.02 -4.25
TAX 7.36 7.39 -0.41 7.36 7.39 -0.41 23.31 31.97 -27.09
Deferred Tax -5.09 -2.39 112.97 -5.09 -2.39 112.97 -13.69 -7.80 75.51
PAT 44.18 35.86 23.20 44.18 35.86 23.20 150.01 149.05 0.64
Equity 126.51 122.17 3.55 126.51 122.17 3.55 126.51 122.17 3.55
PBIDTM(%) 19.23 20.00 -3.85 19.23 20.00 -3.85 19.30 21.89 -11.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..